Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | HTR1E | P28566 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL195772 | 0.92 | KDM4E (0.31) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL213436 | 0.85 | ALDH1A1 (0.35) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL2699253 | 0.85 | ALDH1A1 (0.35) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL6943640 | 0.82 | KDM4E (0.33) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL192060 | 0.82 | KDM4E (0.33) | KDM4EMEN1KMT2ASMN1; SMN2HTR1A | |
| SCHEMBL3060057 | 0.82 | KDM4E (0.33) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL6527091 | 0.82 | OPRK1 (0.35) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL3655351 | 0.82 | KDM4E (0.33) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL11141982 | 0.80 | OPRK1 (0.33) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL127488 | 0.78 | TSHR (0.38) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2010530464-A | — | — | 2010-09-09 | — | — | JP | claimed |
| EP-2160414-A2 | POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP | Bridgestone Corporation (JP) | 2010-03-10 | — | — | EP | claimed |
| WO-2008156788-A2 | POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP | BRIDGESTONE CORPORATION (JP) | 2008-12-24 | — | — | WO | claimed |
| US-20240059846-A1 | REACTIVE MICROPARTICLES AND THEIR USE TO PREPARE FUNCTIONAL HYDROGEL PARTICLES | ALLARTA LIFE SCIENCE INC (CA) | 2024-02-22 | — | — | US | disclosed |
| EP-4255965-A1 | REACTIVE MICROPARTICLES AND THEIR USE TO PREPARE FUNCTIONAL HYDROGEL PARTICLES | Allarta Life Science Inc. (CA) | 2023-10-11 | — | — | EP | disclosed |
| CN-116829621-A | Reactive microparticles and use thereof for preparing functional hydrogel particles | 奥立达生命科学公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2022120478-A1 | REACTIVE MICROPARTICLES AND THEIR USE TO PREPARE FUNCTIONAL HYDROGEL PARTICLES | ALLARTA LIFE SCIENCE INC. (CA) | 2022-06-16 | — | — | WO | disclosed |
| EP-2160414-A2 | POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP | Bridgestone Corporation (JP) | 2010-03-10 | — | — | EP | disclosed |
| WO-2008156788-A2 | POLYMERS FUNCTIONALIZED WITH HALOSILANES CONTAINING AN AMINO GROUP | BRIDGESTONE CORPORATION (JP) | 2008-12-24 | — | — | WO | disclosed |
| US-7238467-B2 | Silver halide emulsion, method of preparing the same and silver halide photosensitive material using the same | FUJIFILM CORPORATION (JP) | 2007-07-03 | — | — | US | disclosed |
| US-6903117-B2 | Indole derivatives for the treatment of osteoporosis | NIKEM RESEARCH S.R.L. (IT) | 2005-06-07 | — | — | US | disclosed |
| EP-0912560-A1 | INDOLE DERIVATIVES FOR THE TREATMENT OF OSTEOPOROSIS | Smithkline Beecham S.p.A. (IT) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998001423-A1 | 5-INDOLYL-2,4-PENTADIENOIC ACID DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION | SMITHKLINE BEECHAM S.P.A. (IT) | 1998-01-15 | — | — | WO | disclosed |
| WO-1998001436-A1 | HETEROAROMATIC PENTADIENOIC ACID DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION | SMITHKLINE BEECHAM S.P.A. (IT) | 1998-01-15 | — | — | WO | disclosed |
| WO-1998001445-A1 | INDOLE DERIVATIVES FOR THE TREATMENT OF OSTEOPOROSIS | SMITHKLINE BEECHAM S.P.A. (IT) | 1998-01-15 | — | — | WO | disclosed |
| WO-1998001443-A1 | INDOLE DERIVATIVES FOR THE TREATMENT OF OSTEOPOROSIS | SMITHKLINE BEECHAM S.P.A. (IT) | 1998-01-15 | — | — | WO | disclosed |
| EP-0802902-A1 | INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS | Smithkline Beecham S.p.A. (IT) | 1997-10-29 | — | — | EP | disclosed |
| EP-0793643-A1 | MATRIX METALLOPROTEASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1997-09-10 | — | — | EP | disclosed |
| WO-1996021644-A1 | INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS | SMITHKLINE BEECHAM S.P.A. (IT) | 1996-07-18 | — | — | WO | disclosed |
| WO-1996016027-A1 | MATRIX METALLOPROTEASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1996-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240059846-A1 | REACTIVE MICROPARTICLES AND THEIR USE TO PREPARE FUNCTIONAL HYDROGEL PARTICLES | LTA, VCL, HBB | KDM4E 2509/4885MEN1 1266/4885KMT2A 2140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.